Sanofi paying Lexicon $260M to exit diabetes alliance

Sanofi will pay $260 million to exit a diabetes drug collaboration with Lexicon Pharmaceuticals, settling a dispute that arose when the French pharma provided notice to Lexicon in July that it would end the partnership.